Clinical Trial Update: A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

View source ↗

Summary

A pediatric natural history study on congenital hearing loss due to OTOF, GJB2, or GJB2/GJB6 mutations has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gjb2 Gjb6-related Deafness
• Gjb2-related Hearing Loss
• Otof-related Congenital Hearing Loss

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF), Biallelic Mutations in the Gap Junction Beta 2 (GJB2) Gene | Status: WITHDRAWN